Cargando…
A Derivate of Benzimidazole-Isoquinolinone Induces SKP2 Transcriptional Inhibition to Exert Anti-Tumor Activity in Glioblastoma Cells
We have previously shown that compound-7g inhibits colorectal cancer cell proliferation and survival by inducing cell cycle arrest and PI3K/AKT/mTOR pathway blockage. However, whether it has the ability to exert antitumor activity in other cancer cells and what is the exact molecular mechanism for i...
Autores principales: | Chen, He-ying, He, Liu-jun, Li, Shi-qiang, Zhang, Ya-jun, Huang, Jiu-hong, Qin, Hong-xia, Wang, Juan-li, Li, Qian-yin, Yang, Dong-lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695871/ https://www.ncbi.nlm.nih.gov/pubmed/31357480 http://dx.doi.org/10.3390/molecules24152722 |
Ejemplares similares
-
Synthesis and Functional Characterization of Substituted Isoquinolinones as MT(2)-Selective Melatoninergic Ligands
por: Hu, Yueqing, et al.
Publicado: (2014) -
Rottlerin exerts its anti-tumor activity through inhibition of Skp2 in breast cancer cells
por: Yin, Xuyuan, et al.
Publicado: (2016) -
Zinc Oxide Nanoparticles Catalyzed Condensation Reaction of Isocoumarins and 1,7-Heptadiamine in the Formation of Bis-Isoquinolinones
por: Krishnakumar, Varadhan, et al.
Publicado: (2012) -
RIOK2 Inhibitor NSC139021 Exerts Anti-Tumor Effects on Glioblastoma via Inducing Skp2-Mediated Cell Cycle Arrest and Apoptosis
por: Yu, Min, et al.
Publicado: (2021) -
MiR-506 exerts antineoplastic effects on osteosarcoma cells via inhibition of the Skp2 oncoprotein
por: Ding, Lu, et al.
Publicado: (2021)